Herranz Martin, Saul saul.herranz@uam.es
Publications
- Articles 9
- Books 0
- Book chapters 0
- Conferences 1
- Working papers 0
- Technical reports 0
- Research projects 1
- Supervised theses 0
- Patent or software license 0
Future Prospects of Gene Therapy for Friedreich's Ataxia
- Ocana-Santero, Gabriel
- Diaz-Nido, Javier
- Herranz-Martin, Saul;
International Journal Of Molecular Sciences (p. 1-18) - 2/2/2021
10.3390/ijms22041815 View at source
- ISSN 14220067
Experimental gene therapies for the NCLs
- Liu W
- kleine-Holthaus SM
- Herranz-Martin S
- Aristorena M
- Mole SE
- Smith AJ
- Ali RR
- Rahim AA
Biochimica Et Biophysica Acta. Molecular Basis Of Disease - 1/9/2020
10.1016/j.bbadis.2020.165772 View at source
- ISSN 09254439
Neonatal brain-directed gene therapy rescues a mouse model of neurodegenerative CLN6 Batten disease
- Holthaus, Sophia-Martha Kleine
- Herranz-Martin, Saul
- Massaro, Giulia
- Aristorena, Mikel
- Hoke, Justin
- Hughes, Michael
- Maswood, Ryea
- Semenyuk, Olha
- Basche, Mark
- Shah, Amna Z.
- Klaska, Izabela P.
- Smith, Alexander J.
- Mole, Sara E.
- Rahim, Ahad
- Ali, Robin R.;
Human Molecular Genetics (p. 3867-3879) - 1/12/2019
10.1093/hmg/ddz210 View at source
- ISSN 14602083
C9orf72 expansion disrupts ATM-mediated chromosomal break repair
- Walker C
- Herranz-Martin S
- Karyka E
- Liao C
- Lewis K
- Elsayed W
- Lukashchuk V
- Chiang S
- Ray S
- Mulcahy P
- Jurga M
- Tsagakis I
- Iannitti T
- Chandran J
- Coldicott I
- De Vos K
- Hassan M
- Higginbottom A
- Shaw P
- Hautbergue G
- Azzouz M
- El-Khamisy S
Nature Neuroscience (p. 1225-1235) - 1/9/2017
10.1038/nn.4604 View at source
- ISSN 10976256
Viral delivery of C9orf72 hexanucleotide repeat expansions in mice leads to repeat-length-dependent neuropathology and behavioural deficits
- Herranz-Martin S
- Chandran J
- Lewis K
- Mulcahy P
- Higginbottom A
- Walker C
- Valenzuela I
- Jones R
- Coldicott I
- Iannitti T
- Akaaboune M
- El-Khamisy S
- Gillingwater T
- Shaw P
- Azzouz M
Disease Models & Mechanisms (p. 859-868) - 1/7/2017
10.1242/dmm.029892 View at source
- ISSN 17548403
CRB2 completes a fully expressed Crumbs complex in the Retinal Pigment Epithelium
- Paniagua A
- Herranz-Martín S
- Jimeno D
- Jimeno Á
- López-Benito S
- Carlos Arévalo J
- Velasco A
- Aijón J
- Lillo C
Scientific Reports - 25/9/2015
10.1038/srep14504 View at source
- ISSN 20452322
Current developments in gene therapy for amyotrophic lateral sclerosis
- Scarrott J
- Herranz-Martín S
- Alrafiah A
- Shaw P
- Azzouz M
Expert Opinion On Biological Therapy (p. 935-947) - 1/7/2015
10.1517/14712598.2015.1044894 View at source
- ISSN 14712598
Gene therapy: A promising approach to treating spinal muscular atrophy
Human Gene Therapy (p. 575-586) - 1/7/2014
10.1089/hum.2013.186 View at source
- ISSN 10430342
Immunocytochemical Evidence of the Localization of the Crumbs Homologue 3 Protein (CRB3) in the Developing and Mature Mouse Retina
Plos One - 30/11/2012
10.1371/journal.pone.0050511 View at source
- ISSN 19326203
This researcher has no books.
This researcher has no book chapters.
Experimental modelling of ALS by AAV-mediated in vivo modulation of the C9ORF72 gene
- Herranz-Martin, Saul
- Lewis, Katherine E.
- Coldicott, Ian
- Chandran, Jayanth S.
- Lukashchuk, Vera
- Iannitti, Tommaso
- Shaw, Pamela J.
- Azzouz, Mimoun;
Human Gene Therapy (p. A16-A16) - 1/1/2016
- ISSN 10430342
- iMarina
This researcher has no working papers.
This researcher has no technical reports.
Regulación del metabolismo energético en el cerebro: Implicaciones para la neurodegeneración en la Ataxia de Friedreich
- Diaz Nido, Javier (Investigador principal (IP))
- Agro, Mauro (Investigador/a)
- Giménez-Cassina Sendón, Alfredo (Investigador/a)
- HERRANZ MARTIN, SAUL (Investigador/a)
Period: 01-06-2020 - 31-05-2023
Type of funding: National
Amount of funding: 108900,00 Euros.
- iMarina
This researcher has no supervised thesis.
This researcher has no patents or software licenses.
Researcher profiles
-
Scopus Author ID
-
Dialnet id